<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Sanofi-Aventis Sa</title><link>https://investorshangout.com/Sanofi-Aventis-Sa-SNYNF-66977/</link><description><![CDATA[Sanofi-Aventis Sa (SNYNF)]]></description><language>en-us</language><pubDate>Wed, 16 Sep 2026 23:18:28 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/Sanofi-Aventis-Sa-SNYNF-66977/" rel="self" type="application/rss+xml"/><item><title>whytestocks: $SNYNF News Article - Press Release: Phase 2 data published in NEJM show potential of frexalimab as </title><link>https://investorshangout.com/post/view?id=6671540</link><guid>https://investorshangout.com/post/view?id=6671540</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 15 Feb 2024 13:20:46 GMT</pubDate></item><item><title>whytestocks: $SNYNF News Article - Press Release: Sarclisa (isatuximab) Phase 3 trial met primary endpoint of pr</title><link>https://investorshangout.com/post/view?id=6650910</link><guid>https://investorshangout.com/post/view?id=6650910</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 07 Dec 2023 13:25:45 GMT</pubDate></item><item><title>whytestocks: $SNYNF News Article - Press Release: Dupixent (dupilumab) Phase 3 Results show sustained efficacy f</title><link>https://investorshangout.com/post/view?id=6635352</link><guid>https://investorshangout.com/post/view?id=6635352</guid><description><![CDATA[whytestocks
]]></description><pubDate>Sun, 22 Oct 2023 19:10:47 GMT</pubDate></item><item><title>whytestocks: $SNYNF News Article - Press Release: Dupixent (dupilumab) sBLA for treatment of eosinophilic esopha</title><link>https://investorshangout.com/post/view?id=6622709</link><guid>https://investorshangout.com/post/view?id=6622709</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 26 Sep 2023 20:30:46 GMT</pubDate></item><item><title>whytestocks: $SNYNF News Article - Press Release: Availability of the Q2 2023 Memorandum for modelling purposes </title><link>https://investorshangout.com/post/view?id=6588574</link><guid>https://investorshangout.com/post/view?id=6588574</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 22 Jun 2023 17:10:49 GMT</pubDate></item><item><title>whytestocks: $SNYNF News Article - Press Release: Sanofi completes acquisition of Provention Bio, Inc. </title><link>https://investorshangout.com/post/view?id=6567275</link><guid>https://investorshangout.com/post/view?id=6567275</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 27 Apr 2023 12:55:46 GMT</pubDate></item><item><title>whytestocks: $SNYNF News Article - Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual a</title><link>https://investorshangout.com/post/view?id=6559180</link><guid>https://investorshangout.com/post/view?id=6559180</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 11 Apr 2023 12:25:46 GMT</pubDate></item><item><title>chartguy89: SNYNF 105.0981 Stock Charts $SNYNF 1 Month Chart </title><link>https://investorshangout.com/post/view?id=1308861</link><guid>https://investorshangout.com/post/view?id=1308861</guid><description><![CDATA[chartguy89
]]></description><pubDate>Mon, 10 Mar 2014 02:57:13 GMT</pubDate></item><item><title>chartguy89: SNYNF Stock Charts Last: +1.85 Saturday, March 1, 2014 at 5:47:25 PM $SNYNF 1 Mo</title><link>https://investorshangout.com/post/view?id=1270239</link><guid>https://investorshangout.com/post/view?id=1270239</guid><description><![CDATA[chartguy89
]]></description><pubDate>Sat, 01 Mar 2014 22:47:37 GMT</pubDate></item></channel></rss>